Suchergebnisse - "Zhang, Lele"

PubPharm (10)

1

Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer : a phase II study

enthalten in: Nature communications | 2023

von Bian, D. | Sun, L. | Hu, J. | +18

2

Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy

enthalten in: Theranostics | 2021

von Zou, L. | Liu, X. | Li, J. | +5

3

Clinical Factors Affecting the Response to Osimertinib in Non-Small Cell Lung Cancer Patients with An Acquired Epidermal Growth Factor Receptor T790M Mutation : A Long-Term Survival Analysis

enthalten in: Targeted oncology | 2020

von Chen, Y. | Wang, S. | Zhang, B. | +5

4

Racial differences in characteristics and prognoses between Asian and white patients with nonsmall cell lung cancer receiving atezolizumab : An ancillary analysis of the POPLAR and OAK studies

enthalten in: International journal of cancer | 2020

von Qian, J. | Nie, W. | Lu, J. | +15

5

Clinical Outcomes of Different Generations of EGFR Tyrosine Kinase Inhibitors in Advanced Lung Adenosquamous Carcinoma

enthalten in: Molecular diagnosis & therapy | 2019

von Hu, M. | Zhang, B. | Xu, J. | +4

6

Management of Central Nervous System Metastases in Patients With Advanced Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer During Crizotinib Treatment

enthalten in: Clinical lung cancer | 2019

von Zhao, Y. | Zhang, B. | Wang, S. | +5

7

Different characteristics and survival in non-small cell lung cancer patients with primary and acquired EGFR T790M mutation

enthalten in: International journal of cancer | 2019

von Wang, S. | Yan, B. | Zhang, Y. | +10

8

Clinical Management of Non-Small Cell Lung Cancer with Concomitant EGFR Mutations and ALK Rearrangements : Efficacy of EGFR Tyrosine Kinase Inhibitors and Crizotinib

enthalten in: Targeted oncology | 2019

von Zhao, Y. | Wang, S. | Zhang, B. | +5

9

Characteristics and Response to Crizotinib in ALK-Rearranged, Advanced Non-Adenocarcinoma, Non-Small Cell Lung Cancer (NA-NSCLC) Patients : a Retrospective Study and Literature Review

enthalten in: Targeted oncology | 2018

von Zhang, B. | Zhang, Y. | Xu, J. | +8

10

Coexistence of sensitive and resistant epidermal growth factor receptor (EGFR) mutations in pretreatment non-small cell lung cancer (NSCLC) patients : First or third generation tyrosine kinase inhibitors (TKIs)?

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2018

von Zhang, B. | Xu, J. | Zhang, X. | +12

1
[1]